In conclusion, the data presented here indicate that aberrant expression of BORIS inhibits apoptosis, promotes proliferation, and attenuates the sensitivity of colorectal cancer cells to 5-FU treatment. This evidence concerns the gene CTCFL and colorectal cancer.